New Collaboration to Test Effect of Combining 2 Immunotherapies
News
BioLineRx, a clinical stage pharmaceutical company signed an agreement with The University of Texas MD Anderson Cancer Center to collaborate on a study investigating how its candidate drug BL-8040 interacts ... Read more